{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T18:13:10Z","timestamp":1767809590852,"version":"3.49.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["rep.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>\u2003<\/jats:title>\n                  <jats:sec>\n                    <jats:title>In brief<\/jats:title>\n                    <jats:p>Preterm birth is the leading cause of perinatal morbidity and mortality, and new therapies that delay preterm birth and improve neonatal outcomes are urgently needed. This study investigates whether ticagrelor inhibits uterine contractility and inflammation in preclinical in vitro, ex vivo (human) and in vivo (mouse) studies, to explore the potential of repurposing ticagrelor for the prevention of preterm birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Preterm birth remains a significant global health challenge, affecting approximately 10% of pregnancies and resulting in one million deaths globally every year. Tocolytic agents, used to manage preterm labour, have considerable limitations including lack of efficacy, and adverse side effects, emphasising the urgent need for innovative solutions. Here, we explore repurposing an antiplatelet cardioprotective drug, ticagrelor, as a potential treatment to prevent preterm birth. Ticagrelor has demonstrated pleiotropic actions beyond platelet inhibition, including relaxant effects on smooth muscle cells and anti-inflammatory effects in models of diabetes and sepsis. As preterm birth is underscored by inflammatory processes triggering uterine contractions, these actions position ticagrelor as an attractive candidate for prevention or delay of preterm birth. Utilising primary human myometrial tissue, human myometrial cells, and a mouse model of preterm birth, we investigated ticagrelor\u2019s potential as a safe and effective therapy for preterm birth. We showed that ticagrelor did not reduce the frequency or strength of spontaneous muscle contractions of ex vivo myometrial tissue nor did it reduce in vitro inflammation-induced contractility in myometrial cells. Additionally, ticagrelor did not exhibit the anticipated anti-inflammatory effects in myometrial cell culture experiments. In our mouse model of preterm birth, ticagrelor neither improved the preterm birth rate or fetal survival outcomes. Gene expression of pro-inflammatory cytokines and contraction-associated proteins in postpartum mouse uteri were unaltered by ticagrelor. In conclusion, ticagrelor is not a strong candidate to continue investigations in clinical trial for the treatment of preterm labour and prevention of preterm birth.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/rep-23-0404","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:46:46Z","timestamp":1704962806000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-11","source":"Crossref","is-referenced-by-count":0,"title":["Investigating ticagrelor in a preclinical pipeline as a novel therapeutic to prevent preterm birth"],"prefix":"10.1093","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0314-378X","authenticated-orcid":false,"given":"Bridget M","family":"Arman","sequence":"first","affiliation":[{"name":"Therapeutics Discovery and Vascular Function in Pregnancy Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie K","family":"Binder","sequence":"additional","affiliation":[{"name":"Therapeutics Discovery and Vascular Function in Pregnancy Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8376-0096","authenticated-orcid":false,"given":"Natasha","family":"de Alwis","sequence":"additional","affiliation":[{"name":"Therapeutics Discovery and Vascular Function in Pregnancy Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally","family":"Beard","sequence":"additional","affiliation":[{"name":"Therapeutics Discovery and Vascular Function in Pregnancy Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali","family":"Garg","sequence":"additional","affiliation":[{"name":"Therapeutics Discovery and Vascular Function in Pregnancy Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u2019uhevaha J","family":"Kaitu\u2019u-Lino","sequence":"additional","affiliation":[{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Australia"},{"name":"Translational Obstetrics Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8446-2250","authenticated-orcid":false,"given":"Natalie J","family":"Hannan","sequence":"additional","affiliation":[{"name":"Therapeutics Discovery and Vascular Function in Pregnancy Group , Department of Obstetrics and Gynaecology, University of Melbourne, Mercy Hospital for Women, Heidelberg, Victoria, Australia"},{"name":"Mercy Perinatal , Mercy Hospital for Women, Heidelberg, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,2,2]]},"reference":[{"key":"2026010712102027000_bib1","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1530\/REP-22-0226","article-title":"Repurposing existing drugs as a therapeutic approach for the prevention of preterm birth","volume":"165","author":"Arman","year":"2023","journal-title":"Reproduction"},{"key":"2026010712102027000_bib2","doi-asserted-by":"publisher","first-page":"5646","DOI":"10.1038\/s41598-023-31077-x","article-title":"Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth","volume":"13","author":"Arman","year":"2023","journal-title":"Scientific Reports"},{"key":"2026010712102027000_bib3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11033-020-06066-2","article-title":"Identification and validation of suitable reference genes for quantitative real-time PCR gene expression analysis in pregnant human myometrium","volume":"48","author":"Arrowsmith","year":"2021","journal-title":"Molecular Biology Reports"},{"key":"2026010712102027000_bib4","doi-asserted-by":"publisher","DOI":"10.3791\/56639","article-title":"Contractility measurements of human uterine smooth muscle to aid drug development","volume":"131","author":"Arrowsmith","year":"2018","journal-title":"Journal of Visualised Experiments"},{"key":"2026010712102027000_bib5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10557-016-6701-2","article-title":"Ticagrelor and rosuvastatin have additive cardioprotective effects via adenosine","volume":"30","author":"Birnbaum","year":"2016","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"Supplement 1","key":"2026010712102027000_bib6","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reproductive Health"},{"key":"2026010712102027000_bib7","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2015.0422","article-title":"Short- and long-term (trophic) purinergic signalling","volume":"371","author":"Burnstock","year":"2016","journal-title":"Philosophical Transactions of the Royal Society B"},{"key":"2026010712102027000_bib8","doi-asserted-by":"publisher","first-page":"e0162506","DOI":"10.1371\/journal.pone.0162506","article-title":"Cross-country individual participant analysis of 4.1 million singleton births in 5 countries with very high human development index confirms known associations but provides no biologic explanation for 2\/3 of all preterm births","volume":"11","author":"Ferrero","year":"2016","journal-title":"PLoS One"},{"key":"2026010712102027000_bib9","doi-asserted-by":"publisher","first-page":"CD004452","DOI":"10.1002\/14651858.CD004452.pub3","article-title":"Oxytocin receptor antagonists for inhibiting preterm labour","volume":"6","author":"Flenady","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"2026010712102027000_bib10","doi-asserted-by":"publisher","first-page":"CD002255","DOI":"10.1002\/14651858.CD002255.pub2","article-title":"Calcium channel blockers for inhibiting preterm labour and birth","volume":"2014","author":"Flenady","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Supplement 2","key":"2026010712102027000_bib11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14767050902860690","article-title":"The preterm parturition syndrome and its implications for understanding the biology, risk assessment, diagnosis, treatment and prevention of preterm birth","volume":"22","author":"Gotsch","year":"2009","journal-title":"Journal of Maternal-Fetal and Neonatal Medicine"},{"key":"2026010712102027000_bib12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.thromres.2011.12.029","article-title":"Ticagrelor, but not clopidogrel and prasugrel, prevents ADP-induced vascular smooth muscle cell contraction: a placebo-controlled study in rats","volume":"130","author":"Grzesk","year":"2012","journal-title":"Thrombosis Research"},{"key":"2026010712102027000_bib13","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s41423-020-0444-5","article-title":"Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y(12) signaling pathway","volume":"18","author":"Huang","year":"2021","journal-title":"Cellular and Molecular Immunology"},{"key":"2026010712102027000_bib15","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.jcin.2017.05.064","article-title":"Comparison of ticagrelor versus prasugrel for inflammation, vascular function, and circulating endothelial progenitor cells in diabetic patients with non-ST-segment elevation acute coronary syndrome requiring coronary stenting: a prospective, randomized, crossover trial","volume":"10","author":"Jeong","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"key":"2026010712102027000_bib16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA","volume":"383","author":"Johnston","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"2026010712102027000_bib17","doi-asserted-by":"publisher","first-page":"e1003892","DOI":"10.1371\/journal.pmed.1003892","article-title":"Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): a multicentre, randomised, double-blinded, placebo-controlled trial","volume":"19","author":"Landman","year":"2022","journal-title":"PLoS Medicine"},{"key":"2026010712102027000_bib18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/bcpt.12752","article-title":"Ticagrelor compared with clopidogrel increased adenosine and cyclic adenosine monophosphate plasma concentration in acute coronary syndrome patients","volume":"120","author":"Li","year":"2017","journal-title":"Basic and Clinical Pharmacology and Toxicology"},{"key":"2026010712102027000_bib19","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s43032-022-00934-x","article-title":"Interventions for infection and inflammation-induced preterm birth: a preclinical systematic review","volume":"30","author":"Miller","year":"2023","journal-title":"Reproductive Sciences"},{"key":"2026010712102027000_bib20","doi-asserted-by":"publisher","first-page":"CD004352","DOI":"10.1002\/14651858.CD004352.pub3","article-title":"Betamimetics for inhibiting preterm labour","volume":"2014","author":"Neilson","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Supplement 2","key":"2026010712102027000_bib21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1365-3016.2001.00007.x","article-title":"The role of infection in preterm labour and delivery","volume":"15","author":"Romero","year":"2001","journal-title":"Paediatric and Perinatal Epidemiology"},{"issue":"Supplement 3","key":"2026010712102027000_bib22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","article-title":"The preterm parturition syndrome","volume":"113","author":"Romero","year":"2006","journal-title":"BJOG"},{"key":"2026010712102027000_bib23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3109\/09537104.2013.842965","article-title":"Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the Plato study","volume":"25","author":"Storey","year":"2014","journal-title":"Platelets"},{"key":"2026010712102027000_bib24","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/ATVBAHA.115.306528","article-title":"Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model","volume":"35","author":"Thomas","year":"2015","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"2026010712102027000_bib25","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.jacc.2012.07.021","article-title":"Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery","volume":"60","author":"Varenhorst","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"2026010712102027000_bib26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.mvr.2018.05.006","article-title":"Ticagrelor protects against AngII-induced endothelial dysfunction by alleviating endoplasmic reticulum stress","volume":"119","author":"Wang","year":"2018","journal-title":"Microvascular Research"},{"key":"2026010712102027000_bib27","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/01.ATV.0000142376.30582.ed","article-title":"ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels","volume":"24","author":"Wihlborg","year":"2004","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"2026010712102027000_bib28","article-title":"WHO recommendation on tocolytic therapy for improving preterm birth outcomes","author":"World Health Organisation","year":"2022","journal-title":"Geneva"},{"key":"2026010712102027000_bib29","doi-asserted-by":"publisher","DOI":"10.3390\/children10030443","article-title":"Tocolytic therapy inhibiting preterm birth in high-risk populations: a systematic review and meta-analysis","volume":"10","author":"Yamaji","year":"2023","journal-title":"Children"}],"container-title":["Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rep.bioscientifica.com\/view\/journals\/rep\/167\/3\/REP-23-0404.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/rep.bioscientifica.com\/downloadpdf\/journals\/rep\/167\/3\/REP-23-0404.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/reproduction\/article-pdf\/167\/3\/e230404\/64910893\/rep-23-0404.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/reproduction\/article-pdf\/167\/3\/e230404\/64910893\/rep-23-0404.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T17:10:30Z","timestamp":1767805830000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/reproduction\/article\/doi\/10.1530\/REP-23-0404\/8217291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,2]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1530\/rep-23-0404","relation":{},"ISSN":["1470-1626","1741-7899"],"issn-type":[{"value":"1470-1626","type":"print"},{"value":"1741-7899","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2,2]]},"published":{"date-parts":[[2024,2,2]]},"article-number":"e230404"}}